ciprofloxacin has been researched along with plumbagin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gryllos, I; Toukoki, C | 1 |
| Gnanamani, A; Iswarya, S; Pavithra, N; Periasamy, H; Senthilnathan, S | 1 |
2 other study(ies) available for ciprofloxacin and plumbagin
| Article | Year |
|---|---|
PolA1, a putative DNA polymerase I, is coexpressed with PerR and contributes to peroxide stress defenses of group A Streptococcus.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; DNA Damage; DNA Polymerase I; Drug Resistance, Bacterial; Gene Expression Regulation, Bacterial; Genetic Variation; Genome, Bacterial; Hydrogen Peroxide; Mutation; Naphthoquinones; Repressor Proteins; Rifampin; Streptococcus pyogenes; Ultraviolet Rays | 2013 |
In vitro antibacterial activity of plumbagin isolated from Plumbago zeylanica L. against methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Cell Wall; Ciprofloxacin; Cytoplasm; Drug Synergism; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Naphthoquinones; Phytochemicals; Piperacillin; Plant Extracts; Plumbaginaceae | 2019 |